전문 번역가, 번역 회사, 웹 페이지 및 자유롭게 사용할 수 있는 번역 저장소 등을 활용합니다.
the syndrome is generally self-limiting.
sindroms parasti izzūd pats.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
furthermore, it follows from the self-limiting
turklāt no komisijas pamatnostādņu radītās pašierobežošanās izriet, ka tai ir jāakceptē, ka prasītāja var iebilst par
마지막 업데이트: 2014-02-06
사용 빈도: 1
품질:
the disease is self-limiting in immunocompetent persons.
slimība ir pašizārstējoša cilvēkiem, kas necieš no imūndeficīta.
마지막 업데이트: 2014-06-03
사용 빈도: 1
품질:
경고: 이 정렬은 잘못되었을 수 있습니다.
잘못된 경우 삭제해 주십시오.
(i) self-limiting effect of the commission guidance
par komisijas pamatnostādņu piemērojamību i) par komisijas pamatnostādņu pašierobežojošo raksturu
마지막 업데이트: 2014-02-06
사용 빈도: 1
품질:
the majority of withdrawal reactions are mild and self-limiting.
līdz ar to mao inhibitori, lietojot remeron, ir relatīvi kontrindicēti.
마지막 업데이트: 2012-04-10
사용 빈도: 2
품질:
these occurrences are generally self-limiting and of short duration.
Šīs pazīmes parasti ir īslaicīgas un beidzas pašas no sevis.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
most events have been self-limiting, however some fatalities have been observed.
vairums gadījumu bija pašierobežojoši, tomēr ir konstatēti daži letāli iznākumi.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
adverse reactions were transient, self limiting and usually mild to moderate in intensity.
nevēlamās blakusparādības bija pārejošas, pašierobežojošas un parasti vieglas līdz vidēji smagas.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
this is usually mild and self-limiting and occurs within 72 hours of injection.
tās parasti ir vieglas, pašas izzūd un tās rodas 72 stundas pēc injekcijas.
마지막 업데이트: 2017-04-26
사용 빈도: 3
품질:
rash was mostly self-limiting and generally resolved within 1 week on continued therapy.
vairumā gadījumu izsitumi bija pašlimitēti un parasti, turpinot terapiju, izzuda 1 nedēļas laikā.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
self-limiting, mild haemoglobin and haematocrit decrease have been observed on initiating gemfibrozil therapy.
uzsākot gemfibrozila terapiju, ir novērota neliela hemoglobīna un hematokrita pazemināšanās, kas pati pāriet.
마지막 업데이트: 2012-04-10
사용 빈도: 2
품질:
rash was mostly self-limiting and generally resolved within 1 to 2 weeks on continued therapy.
vairumā gadījumu izsitumi bija pašlimitēti un, terapiju turpinot, parasti izzuda 1 līdz 2 nedēļu laikā.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
these adverse reactions were self-limiting within one or two days and did not require additional treatment.
Šīs nevēlamās reakcijas izzuda vienas vai divu dienu laikā un nebija nepieciešama papildus terapija.
마지막 업데이트: 2017-04-26
사용 빈도: 3
품질:
these have been generally assessed as non-serious, mild to moderate in severity and self-limiting.
parasti tās novērtētas kā nebūtiskas, vieglas līdz vidēji smagas pakāpes, kas izzūd pašas.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
generally, for ssris and snris, these events are mild to moderate and self-limiting, however, in
5 par pašnāvniecisku domu un pašnāvnieciskas uzvedības gadījumiem ziņots duloksetīna terapijas laikā vai neilgi pēc ārstēšanas pārtraukšanas (skatīt apakšpunktu 4. 4).
마지막 업데이트: 2011-10-23
사용 빈도: 1
품질:
경고: 이 정렬은 잘못되었을 수 있습니다.
잘못된 경우 삭제해 주십시오.
usually, symptoms last for a few days and the disease is self-limiting but occasionally they will persist and result in hospitalisation.
parasti simptomi ilgst dažas dienas un slimība pati pāriet, bet dažreiz simptomi ieilgst un beidzas ar hospitalizāciju.
마지막 업데이트: 2014-06-03
사용 빈도: 1
품질:
경고: 이 정렬은 잘못되었을 수 있습니다.
잘못된 경우 삭제해 주십시오.
the majority of rashes are mild and self-limiting, however serious rashes requiring hospitalisation and discontinuation of lamotrigine have also been reported.
vairumā gadījumu izsitumi ir viegli izteikti un pašierobežojoši, tomēr ir ziņots arī par nopietniem izsitumiem, kuru dēļ nepieciešama hospitalizēšana un lamotrigīna lietošanas pārtraukšana.
마지막 업데이트: 2012-04-10
사용 빈도: 2
품질:
post-marketing experience currently comprises greater than 70,000 vials sold, with two reports of self- limiting allergic reactions.
pieredze pēc vairāk nekā 70 000 flakonu pārdošanas ietver divus ziņojumus par pašierobežojošām alerģiskām reakcijām.
마지막 업데이트: 2017-04-26
사용 빈도: 3
품질:
preclinical studies have suggested that bone formation initiated by truscient is a self-limiting process, forming a well-defined volume of bone.
preklīniskie pētījumi liecina, ka truscient ierosināta kaulu veidošanās ir pašierobežojošs process, veidojot labi definētu kaula tilpumu.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
oral uptake of the product at the maximum recommended dose was well tolerated in cats, apart from some self-limiting salivation and coughing or vomiting immediately after administration.
zāļu iekšķīgai lietošanai maksimāli ieteicamajā devā bija laba panesamība kaķiem, izņemot dažus pārejošus siekalu izdalīšanās un klepus vai vemšanas gadījumus tūlīt pēc lietošanas.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질: